Brennan Kevin M. Insider Trades

Insider Trading History

Track insider trading activity for Brennan Kevin M.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $56.7k 6,371 shares
Last Trade
Jan 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.2k 1,826 shares
$9.40
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $73k 8,197 shares
Last Trade
Jan 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44.8k 5,000 shares
$8.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $89k 10,000 shares
Last Trade
Jan 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44.8k 5,000 shares
$8.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $847k 95,221 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$853k 95,221 shares
$8.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $1.17M 131,700 shares
Last Trade
Nov 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.44M 231,700 shares
$10.54
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $0 0 shares
Last Trade
Nov 21, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.05M 100,000 shares
$10.54
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $28.5k 3,197 shares
Last Trade
Jan 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.77k 1,803 shares
$0.98
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $134k 15,000 shares
Last Trade
Jan 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.78k 5,000 shares
$0.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $44.5k 5,000 shares
Last Trade
Jan 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.78k 5,000 shares
$0.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $534k 60,000 shares
Last Trade
Jan 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.6k 60,000 shares
$0.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $231k 26,000 shares
Last Trade
Oct 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.5k 26,000 shares
$0.75
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $178k 20,000 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.6k 20,000 shares
$1.08
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $178k 20,000 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11k 20,000 shares
$0.55
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $223k 25,000 shares
Last Trade
Aug 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.8k 25,000 shares
$2.79
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Svp, FINANCE AND ACCOUNTING
Holding Value $490k 55,000 shares
Last Trade
Apr 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$174k 55,000 shares
$3.17
$8.90

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up